Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/33106
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHorne M.K.en
dc.contributor.authorParish C.L.en
dc.contributor.authorStanic D.en
dc.contributor.authorDrago J.en
dc.contributor.authorBorrelli E.en
dc.contributor.authorFinkelstein D.I.en
dc.date.accessioned2021-05-14T11:13:39Zen
dc.date.available2021-05-14T11:13:39Zen
dc.date.copyright2002en
dc.date.created20030101en
dc.date.issued2012-10-18en
dc.identifier.citationEuropean Journal of Neuroscience. 16 (5) (pp 787-794), 2002. Date of Publication: 2002.en
dc.identifier.issn0953-816Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/33106en
dc.description.abstractThis study demonstrates that pharmacological manipulation of the dopamine (DA) receptors can modulate the size of the axonal tree of substantia nigra pars compacta (SNpc) neurons in mice. Pharmacological blockade or genetic ablation of the D2 receptor (D2R) resulted in sprouting of DA SNpc neurons whereas treatment with a D2 agonist resulted in pruning of the terminal arbor of these neurons. Agents such as cocaine, that indirectly stimulate D2R, also resulted in reduced terminal arbor. Specific D1 agonists or antagonists had no effect on the density of DA terminals in the striatum. We conclude that the D2 receptor has a central role in regulating the size of the terminal arbor of nigrostriatal neurons. These findings have implications relating to the use of dopaminergic agonists in the management of Parkinson's disease and in controlling plasticity following injury, loss or transplantation of DA neurons.en
dc.languageEnglishen
dc.languageenen
dc.publisherBlackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom)en
dc.titleEffects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1046/j.1460-9568.2002.02132.xen
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid12372014 [http://www.ncbi.nlm.nih.gov/pubmed/?term=12372014]en
dc.identifier.source35463570en
dc.identifier.institution(Parish, Stanic, Drago, Finkelstein, Horne) Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton, Vic. 3168, Australia (Borrelli) Inst. de Genet. Biol. Molec. Cell., B.P. 163, 67404 Illkirch Cedex, Franceen
dc.description.addressM.K. Horne, Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton, Vic. 3168, Australia. E-mail: malcolm.horne@med.monash.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
dc.subect.keywordsMice Parkinson's disease Plasticity Sproutingen
dc.identifier.authoremailHorne M.K.; malcolm.horne@med.monash.edu.auen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

4
checked on Sep 13, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.